Status:
WITHDRAWN
Effect of Avastin in Juxtafoveal Telangiectasias
Lead Sponsor:
Asociación para Evitar la Ceguera en México
Conditions:
Telangiectasis
Eligibility:
All Genders
40-70 years
Phase:
PHASE3
Brief Summary
Evaluation of efficacy of Intravitreal Injection of Bevacizumab in patients with Yuxtafoveal Telangiectasias
Detailed Description
After diagnose Yuxtafoveal telangiectasias secondary to Branch Retinal Vein Occlusion and with Idiopathic Ethiology by clinical signs and Fluorescein angiogram (FA)findings we treated patients with In...
Eligibility Criteria
Inclusion
- Patients with Telangiectasias secondary to Branch Retinal Vein Occlusion
- Patients with Idiopathic Juxtafoveal Retinal Telangiectasias
Exclusion
- Diabetic Retinopathy and Diabetic Macular Edema
- Hypertensive Retinopathy
- Choroidal Neovascularization
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00406380
Start Date
September 1 2006
End Date
November 1 2006
Last Update
May 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asociacion para Evitar la Ceguera en Mexico
Mexico City, Mexico City, Mexico, 04030